MAPT and Alzheimer disease: Overall these observations suggest that the optimal therapeutic strategy against AD should engage multiple allied molecular mechanisms, demonstrating efficacy not only in interfering with the well-known players in AD pathogenesis—i.e., Aβ, tau, neuroinflammation and others—but also in hindering their neurotoxic effects.